These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36444713)

  • 1. Chromatographic Methods for the Determination of Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, and Main Metabolites in Biological Samples: A Review.
    Brozyna-Heredia IY; Ganoza-Yupanqui ML; Moreno-Exebio L; Dos Santos JL
    Crit Rev Anal Chem; 2022 Nov; ():1-16. PubMed ID: 36444713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
    Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
    Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
    Fachi MM; Vilhena RO; Boger B; Domingos EL; Dos Santos JMMF; Junkert AM; de Fátima Cobre A; Momade DRO; Beraldi-Magalhães F; de Liz MV; Cordeiro-Santos M; Pontarolo R
    Biomed Chromatogr; 2020 May; 34(5):e4812. PubMed ID: 32068899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
    Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
    Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
    Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
    J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol.
    Panchagnula R; Sancheti P; Rungta S; Agrawal S; Kaul CL
    Pharmacol Res; 2003 Oct; 48(4):383-7. PubMed ID: 12902209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
    Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
    APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
    Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study.
    Van Aartsen D; Justine M; Mduma E; Mpagama SG; Alshaer MH; Peloquin CA; Mujaga B; Maro A; Gratz J; Kosek M; Liu J; Rogawski McQuade ET; Houpt ER; Thomas TA; Heysell SK
    Lancet Microbe; 2022 Jun; 3(6):e408-e416. PubMed ID: 35659902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    BMC Infect Dis; 2015 Mar; 15():126. PubMed ID: 25887748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
    Lei Q; Wang H; Zhao Y; Dang L; Zhu C; Lv X; Wang H; Zhou J
    Medicine (Baltimore); 2019 Oct; 98(41):e17523. PubMed ID: 31593125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
    Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
    Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk.
    Zuma P; Joubert A; van der Merwe M; Norman J; Waitt C; Court R; Loveday M; Castel S; Wiesner L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123489. PubMed ID: 36215877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.
    Saktiawati AM; Sturkenboom MG; Stienstra Y; Subronto YW; Sumardi ; Kosterink JG; van der Werf TS; Alffenaar JW
    J Antimicrob Chemother; 2016 Mar; 71(3):703-10. PubMed ID: 26661397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
    Mlotha R; Waterhouse D; Dzinjalamala F; Ardrey A; Molyneux E; Davies GR; Ward S
    J Antimicrob Chemother; 2015; 70(6):1798-803. PubMed ID: 25759035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
    Bhutani H; Singh S; Jindal KC; Chakraborti AK
    J Pharm Biomed Anal; 2005 Oct; 39(5):892-9. PubMed ID: 15978767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.